Johnson & Johnson
Executive Director AI-Native Biologics
$173k–$299k base
- Location
- (Multi-state)Hybrid
- Pay
- $173k–$299k base
- Posted
- Posted Nov 19 (employer shows the date only)
- Source
- Workday (employer's applicant tracking system)
- Category
- Engineering/Technology
- Industry
- Pharma/Biotech
Application: Workday — account required, long form — you fill it in on the employer's site.
UNTIL never charges to apply and never asks for payment or personal info on behalf of employers.
Apply kitYour saved details, ready to copy
From the employer's posting
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function:
Discovery & Pre-Clinical/Clinical Development
Job Sub Function:
Biotherapeutics R&D
Job Category:
People Leader
All Job Posting Locations:
Cambridge, Massachusetts, United States of America, Spring House, Pennsylvania, United States of America
Job Description:
ABOUT JOHNSON & JOHNSON INNOVATIVE MEDICINE
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
ABOUT THE OPPORTUNITY
Johnson & Johnson Innovative Medicine is seeking an Executive Director, AI-Native Biologics Modality Engineering, based in Spring House, Pennsylvania or Cambridge, Massachusetts.
This Executive Director, reporting to the VP of Biologics Discovery and a key member of the leadership team, will serve as the senior scientific leader for biologics modality engineering to enable AI-native biologics discovery. The leader will build and lead the scientific capabilities that translate disease biology, therapeutic intent, and computational design into differentiated biologic medicines, with function, developability, manufacturability, safety, and translational quality incorporated from the outset. The leader will connect modality strategy across therapeutic areas, protein engineering, in silico design, functional characterization, and translational quality as one integrated capability. The goal is to deliver molecules for today’s portfolio and to build durable platforms that learn across programs improving performance from discovery through CMC and future clinical development. This is not a stand-alone technology or engineering function. The role will work across In Silico Discovery, Therapeutic Areas, CMC, Safety, Translational Sciences, and Development to create reusable, translatable, and robust modality platforms. These platforms will use data, models, assays, engineering strategies, and decision frameworks to improve candidate choice, resolve downstream risk earlier, and increase the probability of development and clinical success.
KEY RESPONSIBILITIES
MODALITY DESIGN AND FUNCTIONAL QUALITY
• Translate portfolio intent into molecule design. Using AI-assisted tools, convert disease biology, mechanism, and target product profiles into explicit molecular-design and functional criteria across antibodies, multispecifics, ADCs, engineered proteins, and emerging biologic formats.
• Create candidate choice. Generate sufficient molecular diversity and decision-quality predictions and evidence to compare candidates with different strengths and tradeoffs, rather than advancing the first molecule that crosses a minimum threshold.
• Connect sequence, structure, and function. Integrate computational design, protein engineering, biophysical characterization, cell-based functional assays, and translational evidence into coherent design strategies and candidate decisions, while supporting powerful learning loops within the AI-native engine.
AI-NATIVE DISCOVERY EXECUTION
• Operate model-first learning loops. Embed predictive models, active learning, high-throughput experimentation, and automation directly into design-make-test-learn cycles; ensure data are generated to improve future models as well as the current molecule.
• Define the vertical requirements for shared platforms. Partner with In Silico Discovery and self-driving-laboratory leaders to identify the models, data standards, workflows, and automation needed by biologics programs, while avoiding duplicate infrastructure.
• Make performance measurable. Track design-round efficiency, predictive performance, cycle time, candidate diversity, platform reuse, and downstream molecule quality, and use the evidence to improve organizational effectiveness.
TRANSLATIONAL QUALITY FROM THE START
…
Similar live roles
- Reports and Analytics Value Stream Lead
Johnson & Johnson · Posted yesterday - Global Product Manager
Johnson & Johnson · Posted yesterdayNew Brunswick, New Jersey, United States of America - Senior Wire Harness Engineer
Johnson & Johnson · Posted yesterdaySanta Clara, California, United States of America - Associate Director, Planning Data Manager
AstraZeneca · Posted today - Principal Engineer, Aseptic Drug Product Processing
Amgen · Posted today - Assoc. Dir , Information Architecture
Merck · Posted today